Harada, G., Santini, F., Repetti, R., Chang, J. C., Yang, S., Lin, Y., Moses, K. A., Falcon, C. J., Wilhelm, C., Goldstein, M., Makhnin, A., Ginsberg, M. S., Plodkowski, A., Kris, M. G., Drilon, A. E. (2025). Final results of a phase II study of cabozantinib in patients with MET -altered lung cancers.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.8645